Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Adrenergic alpha 2C receptor (α2C adrenoceptor or ADRA2C) is a member of the G protein-coupled receptor (GPCR) superfamily. It regulates neurotransmitter release, insulin secretion, MAPK cascade, smooth muscle contraction, and vasoconstriction. It inhibits adenylate cyclase via Gi/o proteins. Located in the CNS and periphery, it plays a role in presynaptic inhibition and responds to catecholamines like norepinephrine and dopamine.
Inhibition of adenylate cyclase via Gi/o proteins, leading to decreased cAMP levels.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adrenergic alpha 2C receptor (α2C adrenoceptor).